COVID-19 and Diabetes: Understanding the Interrelationship and Risks for a Severe Course

被引:124
|
作者
Landstra, Cyril P. [1 ]
de Koning, Eelco J. P. [1 ]
机构
[1] Leiden Univ, Med Ctr, Dept Internal Med, Leiden, Netherlands
来源
关键词
diabetes; COVID-19; SARS-CoV-2; coronavirus; severity; mortality; comorbidities; treatment; INSULIN-SECRETION; SYSTEM INHIBITORS; OXIDATIVE STRESS; TYPE-2; MORTALITY; HYPERGLYCEMIA; CORONAVIRUS; OUTCOMES; PREVALENCE; COMORBIDITIES;
D O I
10.3389/fendo.2021.649525
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The relationship between COVID-19 and diabetes mellitus is complicated and bidirectional. On the one hand, diabetes mellitus is considered one of the most important risk factors for a severe course of COVID-19. Several factors that are often present in diabetes mellitus are likely to contribute to this risk, such as older age, a proinflammatory and hypercoagulable state, hyperglycemia and underlying comorbidities (hypertension, cardiovascular disease, chronic kidney disease and obesity). On the other hand, a severe COVID-19 infection, and its treatment with steroids, can have a specific negative impact on diabetes itself, leading to worsening of hyperglycemia through increased insulin resistance and reduced beta-cell secretory function. Worsening hyperglycemia can, in turn, adversely affect the course of COVID-19. Although more knowledge gradually surfaces as the pandemic progresses, challenges in understanding the interrelationship between COVID-19 and diabetes remain.
引用
收藏
页数:18
相关论文
共 50 条
  • [21] Understanding the Risks of Immunosuppression Reduction for Active COVID-19 Infection
    Meena, Priti
    Crew, R. John
    KIDNEY INTERNATIONAL REPORTS, 2022, 7 (07): : 937 - 938
  • [22] Understanding risks, mitigation and innovation for surgery in a COVID-19 world
    Birchall, M.
    Blazeby, J.
    Blencowe, N.
    Donovan, J.
    Elliott, D.
    Jepson, M.
    Hutchinson, P.
    Jayne, D.
    Skilton, A.
    BRITISH JOURNAL OF SURGERY, 2020, 107 (08) : E247 - E247
  • [23] Diabetes, obesity, and insulin resistance in COVID-19: molecular interrelationship and therapeutic implications
    Santos, Andrey
    Magro, Daniela Oliveira
    Evangelista-Poderoso, Rosana
    Saad, Mario Jose Abdalla
    DIABETOLOGY & METABOLIC SYNDROME, 2021, 13 (01):
  • [24] Diabetes, obesity, and insulin resistance in COVID-19: molecular interrelationship and therapeutic implications
    Andrey Santos
    Daniéla Oliveira Magro
    Rosana Evangelista-Poderoso
    Mario José Abdalla Saad
    Diabetology & Metabolic Syndrome, 13
  • [25] Microvascular disease in diabetes and severe COVID-19 outcomes
    Corcillo, Antonella
    Whyte, Martin B.
    Vas, Prashanth
    Karalliedde, Janaka
    LANCET DIABETES & ENDOCRINOLOGY, 2021, 9 (04): : 200 - 201
  • [26] Diabetes, Obesity, and Risk Prediction of Severe COVID-19
    Muniyappa, Ranganath
    Wilkins, Kenneth J.
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2020, 105 (10):
  • [27] Current Understanding of COVID-19 Clinical Course and Investigational Treatments
    Aguilar, Richard B.
    Hardigan, Patrick
    Mayi, Bindu
    Sider, Darby
    Piotrkowski, Jared
    Mehta, Jinesh P.
    Dev, Jenankan
    Seijo, Yelenis
    Camargo, Antonio Lewis
    Andux, Luis
    Hagen, Kathleen
    Hernandez, Marlow B.
    FRONTIERS IN MEDICINE, 2020, 7
  • [28] Understanding the effects of Covid-19 through a life course lens
    Settersten, Richard A., Jr.
    Bernardi, Laura
    Harkonen, Juho
    Antonucci, Toni C.
    Dykstra, Pearl A.
    Heckhausen, Jutta
    Kuh, Diana
    Mayer, Karl Ulrich
    Moen, Phyllis
    Mortimer, Jeylan T.
    Mulder, Clara H.
    Smeeding, Timothy M.
    van der Lippe, Tanja
    Hagestad, Gunhild O.
    Kohli, Martin
    Levy, Rene
    Schoon, Ingrid
    Thomson, Elizabeth
    ADVANCES IN LIFE COURSE RESEARCH, 2020, 45
  • [29] Pulmonary Complications are common after a severe Course of COVID-19
    Klein, Friederike
    PNEUMOLOGIE, 2021, 75 (04): : 256 - 256
  • [30] Predictors of severe course of COVID-19 depending on comorbid background
    Pshenichnaya, N.
    Zhuravlev, G.
    Lizinfeld, I.
    INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, 2022, 116 : S44 - S44